Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Valeant Pharmaceuticals (VRX) Stock Jumps Ahead of Monday's Earnings Results

NEW YORK (TheStreet) -- Valeant Pharmaceuticals (VRX - Get Report) stock is gaining 5.72% to $178.53 in midday trading on Friday, ahead of its 2015 third quarter financial results due out before the market open on Monday.

Analysts are expecting the pharmaceutical company to post a year over year rise in earnings and revenue for the most recent quarter.

Valeant Pharmaceuticals has been forecast to report earnings of $2.72 per share on revenue of $2.78 billion by analysts surveyed by Thomson Reuters.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in the next 12-months. Learn more.

Last year, the company reported earnings of $2.11 per share on revenue of $2.1 billion for the 2014 third quarter.

Separately, TheStreet Ratings team rates VALEANT PHARMACEUTICALS INTL as a Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:

We rate VALEANT...


More